AustralianSuper Pty Ltd reveals 5.71% holding in ResMed Inc (NYSE: RMD)

Rhea-AI Filing Summary

AustralianSuper Pty Ltd reported a significant ownership position in ResMed Inc. The investor beneficially owns 8,276,381 ordinary shares of ResMed Inc., representing 5.71% of the class as of June 30, 2026. AustralianSuper has sole power to vote and dispose of all 8,276,381 shares, with no shared voting or dispositive power reported. The filing identifies AustralianSuper as an Australian entity operating as an employee benefit plan and/or investment company, disclosing this stake on a passive Schedule 13G basis.

Key Figures

Shares beneficially owned: 8,276,381 shares Ownership percentage: 5.71% Sole voting power: 8,276,381 shares +3 more

6 metrics

Shares beneficially owned 8,276,381 shares Ordinary Shares of ResMed Inc beneficially owned by AustralianSuper Pty Ltd

Ownership percentage 5.71% Percent of ResMed Inc Ordinary Shares class owned by AustralianSuper Pty Ltd

Sole voting power 8,276,381 shares Shares over which AustralianSuper Pty Ltd has sole power to vote or direct the vote

Shared voting power 0 shares Shares over which AustralianSuper Pty Ltd has shared power to vote or direct the vote

Sole dispositive power 8,276,381 shares Shares over which AustralianSuper Pty Ltd has sole power to dispose or direct disposition

Shared dispositive power 0 shares Shares over which AustralianSuper Pty Ltd has shared power to dispose or direct disposition

Key Terms

Schedule 13G, beneficially owned, Sole Voting Power, Sole Dispositive Power, +1 more

5 terms

Schedule 13G regulatory

"AustralianSuper Pty Ltd files as an investor on a Schedule 13G basis"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficially owned financial

"Ownership (a) | Amount beneficially owned: 8,276,381"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"Sole Voting Power 8,276,381.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"Sole Dispositive Power 8,276,381.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

employee benefit plan and/or investment company financial

"CUSIP Number(s): 761152107 | Employee benefit plan and/or investment company"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/07/2026 - 03:48 PM Accepted by SEC EDGAR 08/07/2026 - 03:47 PM Learn about SEC filing dates

FAQ

What percentage of ResMed Inc (RMD) does AustralianSuper Pty Ltd own?

AustralianSuper Pty Ltd reports beneficial ownership of 5.71% of ResMed Inc’s ordinary shares. This stake corresponds to 8,276,381 shares with sole voting and dispositive power and no shared authority disclosed.

How many ResMed Inc (RMD) shares does AustralianSuper Pty Ltd hold?

AustralianSuper Pty Ltd beneficially owns 8,276,381 ordinary shares of ResMed Inc. It reports sole power to vote and dispose of all these shares and no shared voting or dispositive power.

What type of investor is AustralianSuper Pty Ltd in relation to ResMed Inc (RMD)?

AustralianSuper Pty Ltd is identified as an employee benefit plan and/or investment company. It files on Schedule 13G, which is typically used for investors holding shares without seeking to change or influence control.

Does AustralianSuper Pty Ltd share voting control over ResMed Inc (RMD) shares?

No. AustralianSuper Pty Ltd reports sole voting power over 8,276,381 shares and shared voting power over 0 shares. It likewise has sole dispositive power over 8,276,381 shares and no shared dispositive power.

What class of ResMed Inc (RMD) securities does AustralianSuper Pty Ltd own?

AustralianSuper Pty Ltd holds ResMed Inc Ordinary Shares. The filing identifies the class title as Ordinary Shares and provides the related CUSIP number 761152107 for this security.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

RESMED INC

(Name of Issuer)

Ordinary Shares

(Title of Class of Securities)

761152107

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 761152107

1

Names of Reporting Persons

AustralianSuper Pty Ltd

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

AUSTRALIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 8,276,381.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 8,276,381.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,276,381.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.7 %

12

Type of Reporting Person (See Instructions)

FI

SCHEDULE 13G

Item 1.
(a)	Name of issuer: RESMED INC
(b)	Address of issuer's principal executive offices: 9001 SPECTRUM CENTER BLVD., SAN DIEGO, CALIFORNIA, 92123
Item 2.
(a)	Name of person filing: AustralianSuper Pty Ltd
(b)	Address or principal business office or, if none, residence: Level 30, 130 Lonsdale Street Melbourne Victoria 3000 Australia
(c)	Citizenship: Australia
(d)	Title of class of securities: Ordinary Shares
(e)	CUSIP Number(s): 761152107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
	Employee benefit plan and/or investment company
Item 4.	Ownership
(a)	Amount beneficially owned: 8,276,381
(b)	Percent of class: 5.71%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 8,276,381
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 8,276,381
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AustralianSuper Pty Ltd

Signature:	Amar Rashid
Name/Title:	Principal, Portfolio Compliance
Date:	08/07/2026